Biopharmaceutical benchmarks 2022 Monoclonal antibodies as a group continue to lead biopharmaceuticals in numbers of approvals and sales, although COVID-19 vaccines shot to the top of the list of highest-grossing individual products
The past few years will forever be remembered as the years of a pandemic, the likes of which had not been seen for a century. And biopharmaceuticals took a starring role, with both COVID-19 vaccines and therapeutics dominating the news for the speed with which they were developed and their impact on global health.
Nonetheless, regulatory agencies in both the United States and EU maintained the fast pace of prior years in moving products through their pipelines. This article is the latest survey of biopharmaceutical approvals, which we conduct every four years. The current survey period witnessed the approval of 197 biopharmaceutical products in the United States and/or EU, when counted by product trade name.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID-19 Monoclonal Antibody Treatments No Longer EffectiveThe FDA has said that bebtelovimab, a monoclonal antibody drug given through a vein, is no longer authorized because it is not effective against the leading strains of COVID-19. This drug was the last remaining monoclonal antibody treatment of six that had been authorized for emergency use during the pandemic.
Read more »
Bybit announces second round of layoffs in 2022 to survive bear marketWhile announcing the incoming downsizing, Zhou shared his intent to make the offboarding process as smooth as possible.
Read more »
'Gaslighting' named 2022 Word of the Year by Merriam-WebsterNEW YORK — Merriam-Webster defines gaslighting as 'the act or practice of grossly misleading someone especially for one's own advantage.'
Read more »
2022 Forbes Holiday Gift Guide: An A-To-Z Guide Of Letter-Perfect PresentsGift ideas for all the alphas in your life.
Read more »